Patently-O

SEPTEMBER 26, 2022

Topics: Enablement / Written Description (All three are biotech / pharma): 3 Cases; Infringement (FDA Labeling): 1 Case; Anticipation (On Sale Bar): 1 Case; Double Patenting (Still the law?) I have subjectively ordered the cases with the most important or most likely cases toward the top. Post IPR Estoppel in Apple Inc. Caltech , No.

Patent Law 126

Patent Law Law Patent Invention 126

The IPKat

DECEMBER 29, 2023

This is Trial E, one of the six related trials between Optis and Apple. Trial E determined in particular the terms of a FRAND licence and the conduct of the parties in the negotiations. Findings on specific issues and topics Data regarding the stack Data regarding the stack could not be obtained directly from ETSI.

Patent 78

Patent Litigation Marketing Marketing 78

LexBlog IP

NOVEMBER 30, 2021

In its second decision between the parties on this topic, the court has dismissed the appeal for lack of Article III standing in Apple Inc. § 315(e). Qualcomm Inc. , No 20-1683 (Fed. 10, 2021) (“Apple II”). Background.

Settlement 52

Settlement Licensing Litigation Art 52